Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer.

xlomafota13 shared this article with you from Inoreader Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer. Via radioactive iodine Related Articles Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer. Cancers (Basel). 2020 Nov 06;12(11): Authors: Hartl DM, Guerlain J, Breuskin I, Hadoux J, Baudin E, Al Ghuzlan A, Terroir-Cassou-Mounat M, Lamartina L, Leboulleux S Abstract Many recent publications and guidelines have promoted a "more is less" approach in terms of treatment for low to intermediate risk differentiated thyroid cancer (DTC), which comprise the vast majority of thyroid cancers: less extensive surgery, less radioactive iodine, less or no thyroid hormone suppression, and less frequent or stringent follow-up. Following this approach, thyroid lobectomy has been proposed as a means of decreasing short- and long-term postoperative morbidity while maintaining an excellent prognosis for tumors meeting specific macroscopic and microscopic criteria. This article will examine the pros and cons of thyroid lobectomy for low to intermediate risk cancers and discuss, in detail, criteria for patient selection and oncological outcomes. PMID: 33171949 [PubMed] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.